M&A Deal Summary

Precision BioLogic Acquires Affinity Biologicals

On November 1, 2018, Precision BioLogic acquired medical products company Affinity Biologicals

Acquisition Highlights
  • This is Precision BioLogic’s 1st transaction in the Medical Products sector.
  • This is Precision BioLogic’s 1st transaction in Canada.
  • This is Precision BioLogic’s 1st transaction in Ontario.

M&A Deal Summary
Date 2018-11-01
Target Affinity Biologicals
Sector Medical Products
Buyer(s) Precision BioLogic
Deal Type Add-on Acquisition

Target

Affinity Biologicals

Ancaster, Ontario, Canada
Affinity Biologicals, Inc. is a manufacturer of 300 reagents and kits used in hemostasis and thrombosis research and diagnostics. Affinity's product line includes an extensive line of coagulation-related antibodies, conjugates, matched-pair antibody sets for immunoassay of human and animal analytes, the VisuLize™ line of complete ELISA kits, and a full line of human plasma products including VisuDep™ Immune-Depleted Factor-Deficient Plasmas, VisuCal™ Calibrator Plasma, and VisuCon™ Control Plasmas.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Precision BioLogic

Dartmouth, Nova Scotia, Canada
Category Company
Sector Medical Products
DESCRIPTION

Precision BioLogic, Inc. is a developer, manufacturer, and marketer of the CRYOcheck™ line of frozen products used by medical professionals and researchers around the globe to diagnose coagulation disorders.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Ontario) 1 of 1
Country (Canada) 1 of 1
Year (2018) 1 of 1
Mergr

Product

Company

Legal